IRIX
IRIDEX Corporation
Healthcare · Medical Devices · NCM
$1.09
Data: 2026-05-19
✗ ETHICAL FAIL
MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$18M
Total market value of the company
0.00
Rev Growth
+16.0%
Year-over-year revenue change
Profit Margin
-8.4%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About IRIDEX Corporation
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
25.7% PASS
Debt must be below 33% of total assets
Cash Ratio
34.1% FAIL
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-35.3%
Historical annualised return based on price data
Days in State
20
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | DIZON ROMEO R | Chief Financial Officer | 1,110 | $1,399 | |
| 2026-02-17 | DIZON ROMEO R | Chief Financial Officer | 2,200 | $2,942 | |
| 2026-02-12 | DIZON ROMEO R | Chief Financial Officer | 1,500 | $2,145 | |
| 2026-02-10 | DIZON ROMEO R | Chief Financial Officer | 1,000 | $1,460 | |
| 2026-02-03 | DIZON ROMEO R | Chief Financial Officer | 2,500 | $3,450 | |
| 2026-01-29 | DIZON ROMEO R | Chief Financial Officer | 1,101 | $1,588 | |
| 2026-01-28 | DIZON ROMEO R | Chief Financial Officer | 1,300 | $1,898 | |
| 2026-01-27 | DIZON ROMEO R | Chief Financial Officer | 3,385 | $5,009 | |
| 2026-01-26 | DIZON ROMEO R | Chief Financial Officer | 1,243 | $1,889 | |
| 2026-01-23 | DIZON ROMEO R | Chief Financial Officer | 5,221 | $7,716 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-19